lobbying_activities: 2641713

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2641713	6bb0fbe8-7568-4b77-8786-e1a774a2756e	Q2	TIBER CREEK GROUP	20744	ASTRAZENECA	2021	second_quarter	CPT	S. 1435 - Affordable Prescriptions for Patients Act of 2021; H.R. 2873 - Affordable Prescriptions for Patients Through Promoting Competition Act of 2021.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2021-07-17T11:07:18.730000-04:00